SERPINH1 and cardiac hypertrophy: Additionally, we evaluated the progress of myocardial hypertrophy in these mice and their controls after a shorter 10-day protocol of pressure overload, which once again showed a significant reduction in cardiac hypertrophy in myofibroblast-specific Hsp47-deleted mice (Supplemental Figure 7E).